News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,423 Results
Type
Article (2587)
Company Profile (45)
Press Release (37790)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14295)
Career Advice (78)
Deals (2115)
Drug Delivery (9)
Drug Development (4167)
Employer Resources (10)
FDA (449)
Job Trends (786)
News (20412)
Policy (1066)
Tag
Academia (145)
Allergies (7)
Alliances (3502)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (452)
Artificial intelligence (31)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (333)
Cardiovascular disease (10)
Career advice (66)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (81)
Cervical cancer (2)
Clinical research (3463)
Collaboration (199)
Company closure (2)
Compensation (104)
COVID-19 (185)
CRISPR (11)
C-suite (113)
Cystic fibrosis (7)
Data (425)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (488)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (4548)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6471)
Executive appointments (134)
FDA (595)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (168)
Gene editing (32)
Generative AI (1)
Gene therapy (55)
GLP-1 (64)
Government (159)
Guidances (24)
Healthcare (712)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (197)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (7)
IPO (1006)
IRA (7)
Job creations (297)
Job search strategy (62)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (18)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (319)
Medtech (320)
Mergers & acquisitions (1224)
Metabolic disorders (72)
Multiple sclerosis (22)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (164)
NextGen: Class of 2026 (354)
Non-profit (156)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (53)
Patient recruitment (25)
Peanut (1)
People (5917)
Pharmaceutical (5)
Phase 1 (1488)
Phase 2 (1721)
Phase 3 (918)
Pipeline (391)
Policy (16)
Postmarket research (33)
Preclinical (641)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (62)
Real estate (426)
Recruiting (5)
Regulatory (925)
Reports (7)
Research institute (150)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (20)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (502)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Last 7 days (39)
Last 30 days (148)
Last 365 days (2420)
2026 (212)
2025 (2447)
2024 (2621)
2023 (2874)
2022 (3755)
2021 (4057)
2020 (3483)
2019 (2065)
2018 (1559)
2017 (1833)
2016 (1658)
2015 (1869)
2014 (1388)
2013 (1209)
2012 (1425)
2011 (1351)
2010 (1202)
Location
Africa (44)
Alabama (3)
Arizona (18)
Asia (1953)
Australia (310)
California (1602)
Canada (241)
China (81)
Colorado (54)
Connecticut (16)
Delaware (5)
Europe (4073)
Florida (64)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (48)
Massachusetts (569)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (133)
New York (80)
North Carolina (131)
Northern California (781)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (109)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (653)
Tennessee (4)
Texas (152)
United States (3204)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,423 Results for "enterome bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enterome appoints leading hematologist and IFLI Executive Partner Mehrdad Mobasher, M.D., M.P.H., to its Board of Directors
January 29, 2026
·
3 min read
Press Releases
Enterome OncoMimics™ immunotherapy EO2401 shows survival benefit in Phase 2 glioblastoma trial
December 2, 2025
·
4 min read
Press Releases
Enterome receives FDA Fast Track designation in follicular lymphoma for lead OncoMimics™ immunotherapy EO2463
October 16, 2025
·
4 min read
Press Releases
Enterome to present positive interim Phase 2 data for lead OncoMimics™ immunotherapy EO2463 in follicular lymphoma at American Society for Hematology (ASH) meeting
November 13, 2025
·
5 min read
Enterome to Participate in the 2024 Jefferies Global Healthcare Conference
Enterome announces that Pierre Bélichard, Enterome’s co-founder and Chief Executive Officer, and Christelle Dumoussaud, Chief Financial Officer, will participate in the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY on June 4-6, 2024.
May 30, 2024
·
2 min read
Press Releases
Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma
June 12, 2025
·
7 min read
Press Releases
Enterome to present positive Phase 2 indolent non-Hodgkin lymphoma data for its OncoMimics™ EO2463 at ICML
June 2, 2025
·
4 min read
Press Releases
Enterome presents positive Phase 2 interim results in relapsed/refractory indolent non-Hodgkin lymphoma after EO2463 OncoMimics™ immunotherapy treatment at ICML
June 23, 2025
·
6 min read
Press Releases
Enterome’s Immunotherapy EO2463 Shows Early Clinical Response in Newly Diagnosed Follicular Lymphoma Suggesting a Potential Alternative to ‘Watchful Waiting’
December 11, 2024
·
6 min read
Drug Development
Enterome Announces Successful Completion of Phase 2 ROSALIE Study of EO2401 in Recurrent Glioblastoma
Enterome announced database lock of its Phase 2 study of EO2401, in combination with an immune checkpoint inhibitor +/- an anti-VEGF therapy, for the treatment of patients with recurrent glioblastoma.
April 17, 2024
·
6 min read
1 of 4,043
Next
